| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.28 | 2e-12 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.22 | 8e-09 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-08 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-06 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.24 | 1e-05 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |